{
    "code": "02002238",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02002238",
    "time": "2020-02-25 08:09:58",
    "許可證字號": "衛署藥輸字第002238號",
    "註銷狀態": "已註銷",
    "註銷日期": "79\/09\/27",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "73\/06\/30",
    "發證日期": "62\/07\/17",
    "許可證種類": "製　劑",
    "舊證字號": "02000074",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200223800",
    "中文品名": "收縮寧注射液",
    "英文品名": "SPARTEINE INJECTION &quot;MITA&quot;",
    "適應症": "子宮收縮止血劑",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "SPARTEINE SULFATE",
    "限制項目": "02輸　入",
    "申請商名稱": "0303601100  大陞股份有限公司",
    "申請商地址": "台北巿永康街７５巷１４－１號２樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0383000  TOYO PHARMAR CO. LTD.",
            "製造廠廠址": "885 INAMI, INAMI-MACHI, HIGASHITONAMI-GUN, TOYAMA JAPAN287-1, SHIMOCHO, MOROE-CHO, KANAZAWA CITY, JAPAN",
            "製造廠公司地址": "287-1, SHIMOCHO, MOROE-CHO, KANAZAWA CITY, JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600000910",
            "成分名稱": "SPARTEINE SULFATE",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}